SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001842952-24-000061
Filing Date
2024-08-01
Accepted
2024-08-01 17:15:17
Documents
2
Period of Report
2024-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1722546910.html 3  
1 FORM 3 wk-form3_1722546910.xml 3 1704
2 EX-24 poaforclaudiodanskyullmann.htm EX-24 7496
  Complete submission text file 0001842952-24-000061.txt   10805
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Issuer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address
Dansky Ullmann Claudio (Reporting) CIK: 0002030789 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40654 | Film No.: 241167867